CONFO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

CONFO Trademark

Serial Number: 79176060 • Registration: 4962136

CONFO is a trademark filed by CONFO Therapeutics, afgekort: CONFO, N.V. on July 9, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CONFO Therapeutics, afgekort: CONFO, N.V.

Rijvisschestraat 120

Entity Type: 99

Confo Therapeutics N.V. (10 trademarks)

Technologiepark,

Entity Type: 98

Trademark Details

Filing Date

July 9, 2015

Registration Date

May 24, 2016

Published for Opposition

March 8, 2016

Cancellation Date

July 10, 2025

Goods & Services

Chemicals for scientific use; Biochemicals for in vitro and in vivo scientific use; biochemical substances in particular antibodies for stabilization of proteins, all the aforementioned substances for scientific use and for use in laboratories

scientific research in the field of treating disease; scientific and technological services, namely, research and product design in the field of pharmaceuticals; medical and pharmaceutical research services; laboratory research in the field of pharmaceutical products, particularly the screening of chemical and biochemical substances by means of stabilized proteins

pharmaceutical and veterinary preparations for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; chemical and biochemical substances for pharmaceutical or veterinary use screened by means of stabilized proteins, namely, small molecules and antibodies for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases; veterinary products for use in oncology and immunology and for inflammatory, infection, gastro-intestinal, cardiovascular, pulmonary, neurological, metabolic, systemic, gynecological, urological, dermatological, and musculo-skeletal treatment and treatment of orphan diseases

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jan 22, 2026 DENA
DEATH OF INTERNATIONAL REGISTRATION
Jan 22, 2026 DETH
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 12, 2025 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Feb 14, 2025 CRCV
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 31, 2025 ADCH
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 25, 2023 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 4, 2023 INTS
INVALIDATION PROCESSED
Sep 4, 2023 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Aug 9, 2023 INTR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 31, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 31, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 31, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 31, 2023 REAP
CANCELLED SECTION 71
Dec 9, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 24, 2021 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 30, 2020 ADCH
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 17, 2020 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2020 TCCA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 19, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Nov 29, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 14, 2017 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 25, 2016 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 25, 2016 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 24, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
May 24, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 8, 2016 NPUB
PUBLISHED FOR OPPOSITION
Mar 8, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Mar 4, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 17, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 17, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 17, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 28, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 28, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 28, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 28, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 28, 2016 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 18, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 18, 2015 REAP
REFUSAL PROCESSED BY IB
Dec 4, 2015 RFNT
APPLICATION FILING RECEIPT MAILED
Nov 20, 2015 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2015 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2015 RFCR
NON-FINAL ACTION WRITTEN
Nov 16, 2015 CNRT
ASSIGNED TO EXAMINER
Nov 16, 2015 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 16, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 15, 2015 REPR